Avatar - The Telegraph
The Telegraphadded this to Business
Botox maker Allergan in $63bn swoop by rival AbbVie

AbbVie

Botox maker Allergan in $63bn swoop by rival AbbVie

The Telegraph - By Chris Johnston

Botox maker Allergan is being bought by rival AbbVie for about $63bn (£49bn) in the latest blockbuster deal in the pharmaceutical sector. AbbVie has been under pressure to reduce its reliance on rheumatoid arthritis treatment Humira, the world's best-selling drug that generated sales of about $20bn …

View on telegraph.co.uk
Avatar - The Telegraph

The Telegraph

telegraph.co.uk

Magazines by The Telegraph